2,942
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Formulation, characterization, optimization, and in-vivo performance of febuxostat self-nano-emulsifying system loaded sublingual films

ORCID Icon, , &
Pages 1321-1333 | Received 06 Apr 2021, Accepted 04 May 2021, Published online: 26 Jun 2021

References

  • Abdelbary A , Bendas ER , Ramadan AA , Mostafa DA. (2014). Pharmaceutical and pharmacokinetic evaluation of a novel fast dissolving film formulation of flupentixol dihydrochloride.AAPS PharmSciTech 15:1603–10.
  • Ahuja BK , Jena SK , Paidi SK ,et al. (2015). Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.Int J Pharm 478:540–52.
  • Alhakamy NA , Fahmy UA , Ahmed OAA ,et al. (2020). Development of an optimized febuxostat self-nanoemulsified loaded transdermal film: in-vitro, ex-vivo and in-vivo evaluation.Pharm Dev Technol 25:326–31.
  • Allam A , Fetih G. (2016). Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate.Drug Des Devel Ther 10:2421–33.
  • Alsofany JM , Hamza MY , Abdelbary AA. (2018). Fabrication of nanosuspension directly loaded fast-dissolving films for enhanced oral bioavailability of olmesartan medoxomil: in vitro characterization and pharmacokinetic evaluation in healthy human volunteers.AAPS PharmSciTech 19:2118–32.
  • Balata GF. (2018). Formulation and evaluation of gliclazide in vegetable oil-based self emulsifying delivery system.J Appl Pharm Sci 8:23–33.
  • Bhide P , Cunha JD , Andes NF. (2019). Development and evaluation of febuxostat sublingual tablet formulation development and evaluation of febuxostat sublingual tablet formulation.Int J Pharm Res 10.
  • Bolton S. 2006.Statistics. In: Troy DB , ed. Remington: the science and practice of pharmacy.Baltimore, MD:Lippincott Williams & Wilkins,122–161.
  • Bourtoom T. (2008). Plasticizer effect on the properties of biodegradable blend from rice starch-chitosan.Songklanakarin J Sci Technol 30:149–55.
  • C.Sweetman, S.P.P.L. (2011). Martindale: The Complete Drug Reference 37th ed. London, UK: Pharmaceutical Press.
  • Chonkar AD , Rao JV , Managuli RS ,et al. (2016). Development of fast dissolving oral films containing lercanidipine HCl nanoparticles in semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation.Eur J Pharm Biopharm 103:179–91.
  • Costa P , Lobo JMS. (2001). Modeling and comparison of dissolution profiles.Eur J Pharm Sci 13:123–33.
  • Derringer G , Suich R. (1980). Simultaneous optimization of several response variables.J Qual Technol 12:214–9.
  • El-Bary AA , Al Sharabi I , Haza’a BS. (2019). Effect of casting solvent, film-forming agent and solubilizer on orodispersible films of a polymorphic poorly soluble drug: an in vitro/in silico study.Drug Dev Ind Pharm 45:1751–69.
  • El Nabarawi MA , Shaker DS , Attia DA , Hamed SA. (2013). In-vitro skin permeation and biological evaluation of lornoxicam monolithic transdermal patches.Int J Pharm Pharm Sci 5:242–8.
  • El-Setouhy DA , El-Malak NSA. (2010). Formulation of a novel tianeptine sodium orodispersible film.AAPS PharmSciTech 11:1018–25.
  • El-Shenawy AA , Abdelhafez WA , Ismail A , Kassem AA. (2020). Formulation and characterization of nanosized ethosomal formulations of antigout model drug (Febuxostat) prepared by cold method: in vitro/ex vivo and in vivo assessment.AAPS PharmSciTech 21:1–13.
  • Evans SR. (2010). Clinical trial structures.J Exp Stroke Trans Med 3:8–18.
  • Fahmy RH , Badr-Eldin SM. (2014). Novel delivery approach for ketotifen fumarate: dissofilms formulation using 32 experimental design: in vitro/in vivo evaluation.Pharm Dev Technol 19:521–30.
  • Farid M , El-Setouhy DA , El-Nabarawi MA , El-Bayomi T. (2016). Particle engineering/different film approaches for earlier absorption of meloxicam.Drug Deliv 23:2309–17.
  • Fathei M , Alami-milani M , Salatin S ,et al. (2019). Fast dissolving sublingual strips: a novel approach for the delivery of isosorbide dinitrate.Pharm Sci 25:311–8.
  • Fouda NH , Abdelrehim RT , Hegazy DA , Habib BA. (2018). Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.Drug Deliv 25:1340–9.
  • Franco P , De Marco I. (2020). The use of poly(N-vinyl pyrrolidone) in the delivery of drugs: a review.Polymers (Basel). 12:1114.
  • Gaffo AL , Saag KG. (2009). Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout.Core Evid 4:25–36.
  • Gavini E , Rassu G , Sanna V ,et al. (2005). Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.J Pharm Pharmacol 57:287–94.
  • Grint NJ , Murison PJ. (2008). A comparison of ketamine-midazolam and ketamine-medetomidine combinations for induction of anaesthesia in rabbits.Vet Anaesth Analg 35:113–21.
  • Grizzle JE. (1965). The two-period change-over design and its use in clinical.Biometrics 21:467–80.http://www.jstor.org/stable/2528104.
  • Habib BA , AbouGhaly MHH. (2016). Combined mixture-process variable approach: a suitable statistical tool for nanovesicular systems optimization.Expert Opin Drug Deliv 13:777–88.
  • Hammad RW , Sanad RAB , Abdelmalk NS ,et al. (2018). Intranasal surface-modified mosapride citrate-loaded nanostructured lipid carriers (MOS-SMNLCs) for treatment of reflux diseases: in vitro optimization, pharmacodynamics, and pharmacokinetic studies.AAPS PharmSciTech 19:3791–808.
  • Inugala S , Eedara BB , Sunkavalli S ,et al. (2015). Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: in vitro and in vivo evaluation.Eur J Pharm Sci 74:1–10.
  • Khattab A , Mohamed M , Basalious EB. (2020). Journal of drug delivery science and technology design of self-nanoemulsifying system to enhance absorption and bioavailability of poorly permeable Aliskiren hemi-fumarate.J Drug Deliv Sci Technol 57:101646.
  • Kumar GP , Phani AR , Prasad RGSV ,et al. (2014). Polyvinylpyrrolidone oral films of enrofloxacin: film characterization and drug release.Int J Pharm 471:146–52.
  • Liu L , Wang X. (2008). Solubility-modulated monolithic osmotic pump tablet for atenolol delivery.Eur J Pharm Biopharm 68:298–302.
  • Londhe V , Shirsat R. (2018). Formulation and characterization of fast-dissolving sublingual film of iloperidone using box–behnken design for enhancement of oral bioavailability.AAPS PharmSciTech 19:1392–400.
  • Low AQJ , Parmentier J , Khong YM ,et al. (2013). Effect of type and ratio of solubilising polymer on characteristics of hot-melt extruded orodispersible films.Int J Pharm 455:138–47.
  • Lu EX , Jiang ZQ , Zhang QZ , Jiang XG. (2003). A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent.J Control Release 92:375–82.
  • Mahmood SZ , Sabry HS , Yousif NZ , Salman ZD. (2018). Optimization and evaluation of chlorpheniramine maleate oral strip for pediatric use.Asian J Pharm Clin Res 11:548–54.
  • Mahmoud DB , Shukr MH , Bendas ER. (2014). In vitro and in vivo evaluation of self-nanoemulsifying drug delivery systems of cilostazol for oral and parenteral administration.Int J Pharm 476:60–9.
  • Mura P , Faucci MT , Bramanti G , Corti P. (2000). Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations.Eur J Pharm Sci 9:365–72.
  • Nafee NA , Ismail FA , Boraie NA , Mortada LM. (2003). Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing.Int J Pharm 264:1–14.
  • Patel V , Prajapat B , Patel J , Patel M. (2006). Physicochemical characterization and evaluation of buccal adhesive patches containing propranolol hydrochloride.Curr Drug Deliv 3:325–31.
  • Pouton CW , Porter CJH. (2008). Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.Adv Drug Deliv Rev 60:625–37.
  • Rezaee F , Ganji F. (2018). Formulation, characterization, and optimization of captopril fast-dissolving oral films.AAPS PharmSciTech 19:2203–12.
  • Sallam NM , Sanad RAB , Ahmed MM ,et al. (2020). Impact of the mucoadhesive lyophilized wafer loaded with novel carvedilol nano-spanlastics on biochemical markers in the heart of spontaneously hypertensive rat models.Drug Deliv Trans Res 11:1009–36.
  • Sallam NM , Sanad RAB , kharshoom RM , Zeneldin MA. (2016). Development of salbutamol sulphate sublingual films in pullulan matrix for enhanced bioavailability & clinical efficacy.Curr Drug Deliv 14:503–15.
  • Sayed S , Habib BA , Elsayed GM. (2018). Tri-block co-polymer nanocarriers for enhancement of oral delivery of felodipine: preparation, in vitro characterization and ex vivo permeation.J Liposome Res 28:182–92.
  • Senn S. 2002.Cross-over trials in clinical research.2nd ed. Hoboken, NJ: Wiley.
  • Shamma RN , Sayed S , Sabry NA , El-Samanoudy SI. (2019). Enhanced skin targeting of retinoic acid spanlastics: in vitro characterization and clinical evaluation in acne patients.J Liposome Res 29:283–90.
  • Shen B , De Shen CY , Yuan XD ,et al. (2013). Development and characterization of an orodispersible film containing drug nanoparticles.Eur J Pharm Biopharm 85:1348–56.
  • Shimoda H , Taniguchi K , Nishimura M ,et al. (2009). Preparation of a fast dissolving oral thin film containing dexamethasone: a possible application to antiemesis during cancer chemotherapy.Eur J Pharm Biopharm 73:361–5.
  • Sikarra D , Shukla V , Kharia AA , Chatterjee DP. (2012). Techniques for solubility enhancement of poorly soluble drugs: an overview.J Med Pharm 01:1–22.www.jmpas.com
  • Talekar SD , Haware RV , Dave RH. (2019). Evaluation of self-nanoemulsifying drug delivery systems using multivariate methods to optimize permeability of captopril oral films.Eur J Pharm Sci 130:215–24.
  • Tayel SA , El Nabarawi MA , Amin MM , Abou Ghaly MH. (2016). Sumatriptan succinate sublingual fast dissolving thin films: formulation and in vitro/in vivo evaluation.Pharm Dev Technol 21:328–37.
  • Xiao L , Yi T , Liu Y. (2013). A new self-microemulsifying mouth dissolving film to improve the oral bioavailability of poorly water soluble drugs.Drug Dev Ind Pharm 39:1284–90.
  • Yin YF , Guo Y , Song WD ,et al. (2018). Improving solubility and oral bioavailability of febuxostat by polymer-coated nanomatrix.AAPS PharmSciTech 19:934–40.
  • Younes KM , El-Kady EF , Elzanfaly ES. (2016). Determination of febuxostat in human plasma using RP-LC-UV method.J Chromatogr Sci 54:1022–7.